ChartRow logo
PeersGEHCSNNSTEPHGGMEDDXCM
Share this page

ZBH — Zimmer Biomet Holdings Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in ZBH be worth today? →
ZBH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$110.15
YTD price return
+22.50%
YTD total return
+23.48%
Market cap
20.8B
Enterprise value
28.2B
Shares outstanding
189.3M
52W low
$79.12
52W high
$112.55
From 52W high
-2.13%
From 52W low
+39.22%
52W range
93%$79.12–$113
Beta
0.47

Volume

Rel volume
2.79×
30D volume
2.2M
30D $ vol
209.5M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$824K
Insider net 1Y
−$1.6M

Form 4 transactions by trade date, as filed; latest on file 2026-09-11.

Fundamentals

Sales (ttm)
8.6B
Sales/share
$45.29
EPS (ttm)
$3.95
FCF (ttm)
1.6B
FCF/share
$8.68
Book value/share
$67.19
Net margin
8.95%
ROE
6.03%
ROA
3.26%
Debt / equity
0.49×
Current ratio
1.46

Growth (CAGR, ttm) · 10Y

Sales
+6.99%+5.59%+3.73%+1.15%
Net income
-4.71%+17.39%-1.30%+7.76%
FCF
+10.70%+20.22%+5.74%+2.47%
Shares
-4.51%-3.25%-1.96%-0.57%

Per-share growth (CAGR, ttm) · 10Y

EPS
-2.38%+20.48%+0.29%+8.29%
Sales/share
+12.04%+9.14%+5.80%+1.78%
FCF/share
+15.92%+24.26%+8.00%+3.05%
Book value/share
+4.38%+3.92%+2.01%+3.28%
Dividend/share
+0.00%+0.00%+0.00%+0.21%
Price
+6.76%+0.43%-3.81%+1.02%
Total return
+7.90%+1.38%-2.95%+1.86%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
27.9×
P/OI (ttm)
17.9×
Fwd P/E
11.8×
P/S (ttm)
2.4×
P/B (mrq)
1.6×
P/FCF (ttm)
12.7×
EV/EBITDA (fy)
12.4×
EV/Sales (ttm)
3.3×
FCF yield (ttm)
7.88%
Dividend yield (fwd)Div yield
0.87%
Dividend yield (ttm)
0.87%
Dividend/share (fwd)
$0.96
Buyback yield (realized, 1y)
4.51%
Shareholder yield (realized, 1y)
5.46%
Buyback yield (cash, ttm)
3.98%
Shareholder yield (cash, ttm)
4.87%

Vs own 10Y history

P/E
47th
P/OI
27th
P/S
14th
P/B
16th
P/FCF
14th

Bar = where today’s multiple sits in ZBH’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-04#

1D
+13.49%
5D
+14.28%
1M
+24.76%
3M
+14.97%
YTD
+22.50%
1Y
+6.76%
5Y
-17.64%
1D
+13.49%
5D
+14.28%
1M
+24.76%
3M
+15.27%
YTD
+23.48%
1Y
+7.90%
5Y
-13.91%

Fundamentals#

Revenue

5Y CAGR +6.1%5Y CAGR +6.1%YoY +3.1%
$8.6B TTM$2.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +67.6%10Y CAGR +8.9%YoY −12.4%
$1.2B TTM$307.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m10Y CAGR +16.5%YoY −13.8%
$3.95 TTM$1.00 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +8.9%10Y CAGR +8.0%YoY +33.1%
$1.6B TTM$484.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1.9B, capex −$241.1M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $560M, capex −$75.8M

Shares (diluted)

5Y −4.0%10Y +4.7%YoY −3.7%
194.4M TTM191.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +0.0%10Y CAGR +0.9%YoY +0.0%
$0.96 TTM$0.24 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full ZBH financials →

About Zimmer Biomet Holdings#

Zimmer Biomet Holdings Inc. is a global medical technology company focused on musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip systems, along with sports medicine, biologics, extremities, and trauma solutions. Its portfolio also includes craniomaxillofacial and thoracic products, office-based technologies, bone cement, surgical instruments, and integrated digital and robotic technologies used in orthopedic procedures. Zimmer Biomet serves healthcare professionals, hospitals, and surgical centers by providing products that support the treatment of bone, joint, and soft-tissue disorders. Headquartered in Warsaw, Indiana, Zimmer Biomet plays an important role in orthopedic care across major markets worldwide.

Warsaw, IN·17,000 employees·Medical Devices·zimmerbiomet.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding ZBH#

33 of the 193 ETFs ChartRow carries live hold ZBH. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
XLVHealth Care Select Sector SPDR Fund0.3%
VHTVanguard Health Care ETF0.3%
RSPInvesco S&P 500 Equal Weight ETF0.2%
VBRVanguard Small-Cap Value ETF0.2%
IWSiShares Russell Mid-Cap Value ETF0.2%
VOEVanguard Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
VBVanguard Small-Cap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+24.07%+0.61%
JNJJohnson & Johnson+7.92%+3.81%
ABBVAbbVie Inc.+12.18%+3.09%
MRKMerck & Co. Inc.+4.20%+3.93%
UNHUnitedHealth Group Incorporated Common Stock (DE)+10.08%+1.22%
NVSNovartis AG+17.01%+3.59%
TMOThermo Fisher Scientific Inc.+7.84%+1.12%
AMGNAmgen Inc.+18.69%+3.71%